Dialysis of Little Benefit to Elderly End-Stage Renal Disease Patients

This article originally appeared here.
Share this content:
Dialysis of Little Benefit to Elderly End-Stage Renal Disease Patients
Dialysis of Little Benefit to Elderly End-Stage Renal Disease Patients

FRIDAY, March 18, 2016 (HealthDay News) -- Dialysis does not significantly improve survival for elderly patients with end-stage renal disease (ESRD), according to research published online March 17 in the Clinical Journal of the American Society of Nephrology.

Wouter Verberne, M.D., of St. Antonius Hospital in Nieuwegein, Netherlands, and colleagues examined outcomes among older (≥70 years) ESRD patients in the Netherlands who received either dialysis (204 patients) or conservative care (107 patients).

Overall, patients with comorbidities died sooner than those without additional medical issues, the study authors reported. Among those ≥80 years of age, the investigators found no statistically significant difference in survival between dialysis and conservative care. The findings suggest that conservative care may be a reasonable option for some ESRD patients ≥80.

"We do not conclude that dialysis treatment should not be given to anybody ≥80 years or with severe comorbidity. But we show that the treatment is on average of little advantage regarding survival," Verberne said in a journal news release. "Our next task is to predict who benefits and who does not. Until we are able to give a better prediction of the results of dialysis treatment at high age, we can merely suggest that conservative management is an option which should honestly be discussed when ESRD is approaching."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »